• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>C.R. Bard

C.R. Bard

CR Bard Inc BCR 2 Star

Last Price$172.77Day Change (%)1.21%
Open Price$171.75Day Change ($)2.07
Day Range171.35–173.0052-Week Range141.49–180.94

As of Wed 7/1/2015 5:50:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Research and Markets: United States Urinary Slings Market 2015-2019 with American Medical System, Boston Scientific, Coloplast, C.R . Bard & Ethicon Dominating

    Research and Markets: United States Urinary Slings Market 2015-2019 with American Medical System, Boston Scientific, Coloplast, C.R . Bard & Ethicon Dominating

  2. Bard to Host Earnings Conference Call on July 23, 2015

    Bard to Host Earnings Conference Call on July 23, 2015

  3. Research and Markets: Global Incontinence Care Products and Devices Market Assessment & Forecast 2015-2019

    Research and Markets: Global Incontinence Care Products and Devices Market Assessment & Forecast 2015-2019

  4. Research and Markets: Catheter Stabilization Device/Catheter Securement Devices Market by Product, Application, End User - Global Forecast to 2020

    Research and Markets: Catheter Stabilization Device/Catheter Securement Devices Market by Product, Application, End User - Global Forecast to 2020

  5. Research and Markets: Cancer Diagnostics Market by Technology, Imaging and by Application - Forecast to 2020

    Research and Markets: Cancer Diagnostics Market by Technology, Imaging and by Application - Forecast to 2020

  6. Asuragen Announces Launch of Highly Sensitive CE-IVD BCR -ABL Assay at the European Hematology Association Annual Congress

    Asuragen Announces Launch of Highly Sensitive CE-IVD BCR -ABL Assay at the European Hematology Association Annual Congress

  7. Research and Markets: US Central Venous Access Devices Market Report 2015

    Research and Markets: US Central Venous Access Devices Market Report 2015

  8. Research and Markets: Peripheral IV Catheter Market in the US 2015-2019 with B. Braun Melsungen, Tangent Medical Technologies and Terumo Dominating

    Research and Markets: Peripheral IV Catheter Market in the US 2015-2019 with B. Braun Melsungen, Tangent Medical Technologies and Terumo Dominating

  9. ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib from Phase 2 Pace Clinical Trial

    ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib from Phase 2 Pace Clinical Trial

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.